Joseph Tucker, Chief Executive Officer, MagicMed Industries Inc. gave presentation at the Psychedelic Capital Sept 3rd- The gold standard for psychedelic investment. MagicMed Industries intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products.

MagicMed’s molecular derivatives library, the Psybrary™ is anticipated to be an essential building block from which industry can develop new patented products. The initial focus of the Psybrary™ is on psilocybin, and is expected to be opportunistically expanded to other psychedelics like MDMA, ketamine, ibogaine, mescaline, and ayahuasca. Joseph Tucker Chief Executive Officer, MagicMed Industries Inc.